Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
Saved in:
| Title: | Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease. |
|---|---|
| Authors: | Aye WWT; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Stark MR; New Zealand Brain Research Institute Christchurch New Zealand., Horne KL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Livingston L; New Zealand Brain Research Institute Christchurch New Zealand., Grenfell S; New Zealand Brain Research Institute Christchurch New Zealand., Myall DJ; New Zealand Brain Research Institute Christchurch New Zealand., Pitcher TL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Almuqbel MM; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand., Keenan RJ; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand., Meissner WG; New Zealand Brain Research Institute Christchurch New Zealand.; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives IMNc, NS-Park/FCRIN Network Bordeaux France.; Univ. Bordeaux, CNRS, IMN Bordeaux France., Dalrymple-Alford JC; New Zealand Brain Research Institute Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand., Anderson TJ; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand., Heron CL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand., Melzer TR; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand. |
| Source: | Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2024 Jun 22; Vol. 16 (2), pp. e12601. Date of Electronic Publication: 2024 Jun 22 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2352-8729 |
|---|---|
| DOI: | 10.1002/dad2.12601 |
